Quoin Pharmaceuticals, Ltd.
QNRX
$6.52
-$0.085-1.29%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -12.75% | -21.97% | 6.31% | 10.60% | -2.44% |
| Total Depreciation and Amortization | -2.72% | -3.85% | -3.85% | -3.85% | -1.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 31.90% | 90.76% | 72.91% | 63.64% | -77.98% |
| Change in Net Operating Assets | 84.87% | -122.70% | -201.82% | -6.28% | -61.17% |
| Cash from Operations | 30.62% | -64.91% | -27.62% | 17.87% | -65.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -220.21% | 325,000.00% | 3.95% | -27.90% | -- |
| Cash from Investing | -220.21% | 325,000.00% | 3.95% | -27.90% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 45.45% | -100.00% | -50.00% | 67.51% |
| Issuance of Common Stock | -- | -- | -- | -6.27% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -177.62% |
| Cash from Financing | 3,342.83% | 45.49% | -81.73% | -7.25% | 59.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.47% | 117.02% | -27.08% | -211.05% | 68.10% |